Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to "In Vivo Multiplexed Analysis of Aminopeptidase Activities by Hyperpolarized Molecular Probes for Tumor Diagnostic Applications".

Journal of the American Chemical Society·2026
Same author

Correction to "Perfluorinated Iridium Catalyst for Signal Amplification by Reversible Exchange Provides Metal-Free Aqueous Hyperpolarized [1-<sup>13</sup>C]-Pyruvate".

Journal of the American Chemical Society·2026
Same author

In Vivo Multiplexed Analysis of Aminopeptidase Activities by Hyperpolarized Molecular Probes for Tumor Diagnostic Applications.

Journal of the American Chemical Society·2026
Same author

Band-Selective IR PRESS for Brain Tumor Spectroscopy Allows Robust Detection of Lactate.

NMR in biomedicine·2026
Same author

Multidimensional pH-Temperature Mapping of SABRE-SHEATH <sup>13</sup>C Hyperpolarization of [1-<sup>13</sup>C]Pyruvate.

The journal of physical chemistry. B·2025
Same author

In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water.

Research square·2025
Same journal

Nanotechnology-Empowered Photodynamic Therapy for Improved Oral Cancer Treatment.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Design, Synthesis, Spectroscopic Analysis, and In Silico Molecular Docking Study of Novel Azo Compounds as Potential Antioxidant and Anti-Triple-Negative Breast Cancer Agents.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Plant-Derived Polyphenols in the Fight against Colorectal Cancer.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Emerging Frontiers in Nanomedicine for Colorectal Cancer: A Review of Therapeutic Advances, Clinical Evidence, and Patented Technologies.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Microfluidic Synthesis of miR-10a Antisense Oligonucleotides-Loaded LNP Combined with Cisplatin for Colorectal Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Synergistic Anticancer Effect of Luteolin and Etoposide via the PI3K/AKT Signaling Pathway.

Anti-cancer agents in medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Nitroxides as cancer imaging agents.

Ryan M Davis1, James B Mitchell, Murali C Krishna

  • 1Radiation Biology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA. davisrm2@mail.nih.gov

Anti-Cancer Agents in Medicinal Chemistry
|March 26, 2011
PubMed
Summary
This summary is machine-generated.

Nitroxides, acting as superoxide dismutase mimics, offer antioxidant and radioprotective benefits. Their paramagnetic properties enable imaging, and their metabolism reflects tissue redox status, relevant for oncology applications.

More Related Videos

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging

Published on: November 20, 2018

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Experiment Videos

Last Updated: Jun 3, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging

Published on: November 20, 2018

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Area of Science:

  • Biochemistry
  • Medical Imaging
  • Pharmacology

Background:

  • Nitroxides are low molecular weight compounds with antioxidant, radical scavenging, and radioprotective properties.
  • Their paramagnetic nature allows use as spin probes and MRI contrast agents for in vivo monitoring.
  • Nitroxide metabolism, primarily reduction to hydroxylamines, is influenced by oxidative stress, indicating potential as a redox status assay.

Purpose of the Study:

  • To review the clinical applications of nitroxides.
  • To focus on biochemical and tumor microenvironmental factors influencing nitroxide reduction rates.
  • To discuss therapeutic potential and bio-reduction mechanisms in oncology.

Main Methods:

  • Literature review of nitroxide properties and applications.
  • Analysis of factors affecting nitroxide metabolism in biological systems.
  • Discussion of nitroxide reduction mechanisms relevant to cancer.

Main Results:

  • Nitroxides exhibit diverse biological activities including antioxidant and radioprotective effects.
  • Nitroxide metabolism rates can serve as an indicator of tissue redox state.
  • Factors influencing nitroxide reduction are crucial for their application in oncology.

Conclusions:

  • Nitroxides hold promise for clinical applications due to their antioxidant and imaging capabilities.
  • Understanding nitroxide bio-reduction is key to leveraging their therapeutic potential in oncology.
  • Nitroxide metabolism assays can provide insights into tissue redox status for cancer research.